Afghanistan
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Afghanistan (AF)
| 2011 | 818.3 thousand |
| 2024 | 1.9 million |
| 2050 | 4.8 million |
Afghanistan is one of the 21 countries and territories in the IDF Middle-East and North Africa Region.
Data source(s) used for the diabetes estimates in adults:
- Ministry of Public Health, WHO STEPS, 2018
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 818.3 | 1,932.8 | 4,755.9 |
| Age-standardised prevalence of diabetes, % | - | 7.6 | 11.7 | 12.7 |
| Proportion of people with undiagnosed diabetes, % | - | - | 71.4 | - |
| People with undiagnosed diabetes, in 1,000s | - | 409.2 | 1,379.7 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 946.3 | 2,192.3 |
| Age-standardised prevalence of IFG, % | - | - | 5.0 | 5.2 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 819.8 | 1,369.8 | 3,293.9 |
| Age-standardised prevalence of IGT, % | - | 7.2 | 8.7 | 9.1 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 15,568.0 | 11,641.7 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.4 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 266.4 | 589.3 |
| Total diabetes-related health expenditure, ID million | - | - | 996.1 | 2,203.8 |
| Diabetes-related health expenditure per person, USD | - | - | 137.8 | 123.9 |
| Diabetes-related health expenditure per person, ID | - | - | 515.4 | 463.4 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 13,600.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 7,255.3 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 13,733.0 | 19,857.7 | 43,246.2 |
| Population of children and adolescents (0-19 y) | - | - | 23,062,380.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
